Strategic Research Institute, Doubletree Paradise Valley Resort
March 29-31, 2005
Strategies to Protect and Maximize Profits from Discovery to DrugsCONFERENCE PURPOSE:
To enhance networking between pharma & biotech industry leaders, law firms, and USPTO professionals, and to disseminate information on the latest developments in the Intellectual Property and Patent field. FEATURED PRESENTATIONS: The Written Description Requirement: The Bain of Biotechnology Patenting Stephen Kunin
Formerly Deputy Commissioner for Patent Examination Policy
UNITED STATES PATENT & TRADEMARK OFFICE (USPTO)
Maintaining and Extending a Franchise's Life-Cycle Martin Voet, J.D.
Senior Vice President & Chief Intellectual Property Counsel
ALLERGAN, INC.
The Year in Review: The Most Significant Biotech/Pharma I.P. Developments Wainwright Fishburn, J.D.
Attorney at Law & Founding Partner
COOLEY GODWARD LLP
PRE-CONFERENCE WORKSHOP: How to Protect Your Intellectual Property Biotech Boot Camp: Legal Basics Patent Portfolio Management Issues
Ownership Issues Faced by Biotech Companies, Including Start-ups, and Academia
Corporate Issues & Tax Matters
OTHER TOPICS INCLUDE: Assessing the Patent Environment for Generic Biologics
Patent & License Exchanges – Will the eBay Model EverApply to Biotech I.P.?
Patent Licensing in Antibody Therapeutic Discovery and Development
Intellectual Property Developments Affecting New Biotechnologies: RNAi & Stem Cells
A Patent Primer for Entrepreneurs & General Counsels: Protecting and Building a Comprehensive Intellectual Property Portfolio
The Interplay of Trade Secrets and Patents
Pre-Litigation Review of Your Docket: How to Assure That Your Portfolio and Your Company Are Ready for Litigation
Licensing Technologies and Intellectual Property Rights from Universities – The Do's and Dont's!
MCLE Application Pending CONCURRENT WITH The Annual Pharma & Biotech Licensing & Deal-Making Summit - ATTEND BOTH!
|